chr1-182473713-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001137669.2(RGSL1):c.602C>A(p.Thr201Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000715 in 1,399,500 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001137669.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000628 AC: 1AN: 159174Hom.: 0 AF XY: 0.0000120 AC XY: 1AN XY: 83596
GnomAD4 exome AF: 7.15e-7 AC: 1AN: 1399500Hom.: 0 Cov.: 30 AF XY: 0.00000145 AC XY: 1AN XY: 690258
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.602C>A (p.T201N) alteration is located in exon 6 (coding exon 6) of the RGSL1 gene. This alteration results from a C to A substitution at nucleotide position 602, causing the threonine (T) at amino acid position 201 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at